HeartMate 3

DEVICE4 trials

Sponsors

Evaheart, Inc., Abbott Medical Devices, Institute for Clinical and Experimental Medicine, BrioHealth Solutions, Inc.

Conditions

Cardiovascular DiseaseCardiovascular DiseasesHeart DiseasesHeart FailureLVAD (Left Ventricular Assist Device) ThrombosisVentricular Dysfunction

Unknown Phase

Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System

SuspendedNCT01187368

Evaheart, Inc.Heart Failure

Start: 2020-03-31End: 2028-07-31Target: 399Updated: 2026-03-27

HeartMate 3 ELEVATE™ Registry

CompletedNCT02497950

Abbott Medical DevicesCardiovascular Disease, Heart Failure, Ventricular Dysfunction

Start: 2015-10-13End: 2022-02-28Updated: 2025-03-20

DOT HeartMate 3 Study

CompletedNCT04974684

Institute for Clinical and Experimental MedicineLVAD (Left Ventricular Assist Device) Thrombosis

Start: 2022-04-01End: 2024-03-01Updated: 2024-08-20

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

RecruitingNCT06310031

BrioHealth Solutions, Inc.Cardiovascular Diseases, Heart Diseases, Heart Failure

Start: 2024-10-28End: 2028-12-01Target: 780Updated: 2026-09-09

Related Papers

Concomitant tricuspid valve surgery during heartmate 3 LVAD implantation and long-term outcomes: Insights from the ELEVATE registry

European Journal of Cardio-Thoracic Surgery2026-03-23

Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry

European Heart Journal2020-08-0474 citations

Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry

European Heart Journal2018-08-0569 citations